Blood Test Identifies Acute Myeloid Leukemia Patients at Risk for Relapse
Research shows benefits of screening patients in remission from acute myeloid leukemia for residual disease prior to a bone marrow transplant.
Read MorePosted by Andy Lundin | Mar 9, 2023 | Leukemia |
Research shows benefits of screening patients in remission from acute myeloid leukemia for residual disease prior to a bone marrow transplant.
Read MorePosted by Andy Lundin | Mar 3, 2023 | Urine Analyzers |
Researchers developed a urine sensor that can amplify the light signal of metabolites in urine and in diagnosing cancer in the field.
Read MorePosted by Andy Lundin | Mar 3, 2023 | Lab Automation, Molecular Diagnostics |
Automated NGS platforms can help determine if a patient is fit for a targeted therapy, enabling more effective precision medicine.
Read MorePosted by Chris Wolski | Mar 2, 2023 | Prostate, Unknown Origin & Other Cancer Types |
Veracyte CEO Marc Stapley outlines how single-cancer testing is giving pathologists, clinicians, and patients an edge.
Read MorePosted by Andy Lundin | Feb 27, 2023 | Infectious Diseases |
Researchers have recommended a method to help diagnose preschool age children with primary ciliary dyskinesia (PCD).
Read More